News Releases

October 20, 2015

First Participants Enrolled in RepliCel’s Phase 1 Clinical Trial of its RCS-01 Dermatology Injectable
Testing the use of a cell-based injectable as a regenerative alternative for the global dermal filler market addressing aged and UV-damaged skin  VANCOUVER, BC... Read full article

October 15, 2015

Industry Leader Geoff MacKay Joins RepliCel Life Sciences’ Board of Directors
VANCOUVER, BC – October 15, 2015 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP), a clinical stage regenerative medicine company focused on the... Read full article

October 8, 2015

RepliCel Announces October Presentation and Partnering Meeting Schedule
VANCOUVER, BC – October 8, 2015 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP), a clinical stage regenerative medicine company focused on the... Read full article

September 23, 2015

RepliCel Presenting at Two Upcoming Investment and Partnering Forums
A Chinese-based investor forum in Toronto and an aesthetics & dermatology conference in Newport Beach showcase RepliCel among industry leaders, high-growth companies and active... Read full article

September 15, 2015

RepliCel Life Sciences Announces Initiation of Clinical Site and Participant Recruitment for European Skin Aging Study
Clinical trial site located at IUF Leibniz-Institut für umweltmedizinische Forschung GmbH in Germany VANCOUVER, BC – September 15, 2015 – RepliCel Life Sciences Inc.... Read full article

September 1, 2015

RepliCel Life Sciences Cleared to Initiate Clinical Trial of RCS-01 for Dermal Rejuvenation
Patient recruitment will take place at the IUF Leibniz-Institut für umweltmedizinische Forschung GmbH in Germany VANCOUVER, BC – September 1, 2015 – RepliCel Life... Read full article

August 28, 2015

RepliCel Reports Second Quarter 2015 Financial Results
VANCOUVER, BC – August 28, 2015 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP), a clinical stage regenerative medicine company focused on the... Read full article

August 3, 2015

RepliCel Presenting at InvestMNT Investor Conference in Minneapolis
Conference attracts investment professionals in the Twin Cities area VANCOUVER, BC – August 3, 2015 – RepliCel Life Sciences Inc. (TSX.V: RP) (OTCQB: REPCF),... Read full article

July 29, 2015

RepliCel Life Sciences Unveils Innovative Dermal Injector Prototype
Novel features of next-generation design promise to serve and expand the dermal injectable market VANCOUVER, BC – July 29, 2015 – RepliCel Life Sciences... Read full article

July 21, 2015

RepliCel Receives Two Important Approvals for Dermal Rejuvenation Clinical Trial
German-based trial to test RCS-01 cell therapy treatment for aged and sun-damaged skin VANCOUVER, BC – July 21, 2015 – RepliCel Life Sciences Inc.... Read full article